United States · FDA National Drug Code directory
Verkazia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82667-014_535cafb4-abf9-92cb-e063-6394a90aa3d0
- Product NDC
- 82667-014
- Form
- EMULSION
- Composition / generic term
- cyclosporine
- Labeler
- Harrow Eye, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220201
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOSPORINE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 POUCH in 1 CARTON (82667-014-00) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .3 mL in 1 VIAL, SINGLE-DOSE · 82667-014-00
- 24 POUCH in 1 CARTON (82667-014-01) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .3 mL in 1 VIAL, SINGLE-DOSE · 82667-014-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →